Nipolazin


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 10.8%
Hypertension 9.4%
Antitussive Therapy 8.6%
Diuretic Therapy 8.6%
Drug Eruption 8.6%
Eczema 7.9%
Otitis Media Acute 7.2%
Diabetes Mellitus 5.8%
Nasopharyngitis 5.0%
Product Used For Unknown Indication 5.0%
Liver Disorder 4.3%
Cough 2.9%
Urticaria 2.9%
Analgesic Therapy 2.2%
Dermatitis Atopic 2.2%
Hyperlipidaemia 2.2%
Pancreatic Carcinoma 2.2%
Colon Cancer Metastatic 1.4%
Influenza 1.4%
Labyrinthitis 1.4%
Rhabdomyolysis 16.7%
Leukoencephalopathy 11.1%
Liver Disorder 11.1%
Speech Disorder 11.1%
White Blood Cell Count Decreased 11.1%
Blood Pressure Increased 5.6%
Faeces Discoloured 5.6%
Interstitial Lung Disease 5.6%
Pelvic Venous Thrombosis 5.6%
Pyrexia 5.6%
Renal Impairment 5.6%
Transfusion-related Acute Lung Injury 5.6%
Concomitant
Pustular Psoriasis 9.5%
Hypertension 9.3%
Rheumatoid Arthritis 7.8%
Prophylaxis 7.6%
Drug Use For Unknown Indication 7.0%
Asthma 5.2%
Chronic Myeloid Leukaemia 4.9%
Insomnia 4.9%
Oncologic Complication 4.7%
Product Used For Unknown Indication 4.5%
Tonsillitis 4.5%
Rash 4.1%
Acute Myeloid Leukaemia 3.9%
Gastric Ulcer 3.9%
Gastrointestinal Disorder 3.9%
Pruritus 3.3%
Bronchitis 3.1%
Antifungal Prophylaxis 2.9%
Influenza 2.9%
Angina Pectoris 2.3%
Rash 8.2%
Syncope 8.2%
Thyroid Cancer 8.2%
Abnormal Behaviour 6.8%
Malaise 6.8%
Stomatitis 6.8%
Palmar-plantar Erythrodysaesthesia Syndrome 5.5%
Pyrexia 5.5%
Staphylococcal Infection 5.5%
Gastrointestinal Haemorrhage 4.1%
Liver Disorder 4.1%
Overdose 4.1%
Pneumonia Aspiration 4.1%
Restlessness 4.1%
Vomiting 4.1%
Altered State Of Consciousness 2.7%
Aortic Dissection 2.7%
Blood Phosphorus Decreased 2.7%
Cardio-respiratory Arrest 2.7%
Depression Suicidal 2.7%

Drug Data